Oppenheimer Assumes Everus (ECG) at Outperform
Tweet Send to a Friend
Oppenheimer analyst Brent Thielman assumes coverage on Everus (NYSE: ECG) with a Outperform rating and a price target of $185.00.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


